MediPharm Labs Corp. (TSE:LABS – Get Free Report) hit a new 52-week high on Monday . The company traded as high as C$0.12 and last traded at C$0.11, with a volume of 453968 shares traded. The stock had previously closed at C$0.11.
MediPharm Labs Stock Performance
The business has a 50-day moving average of C$0.07 and a two-hundred day moving average of C$0.07. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10. The company has a market cap of C$47.72 million, a P/E ratio of -3.96 and a beta of 0.88.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Health Care Stocks Explained: Why You Might Want to Invest
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Investing in Construction Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
